These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35787415)

  • 1. Management of dyslipidemia and atherosclerotic cardiovascular risk in prediabetes.
    Neves JS; Newman C; Bostrom JA; Buysschaert M; Newman JD; Medina JL; Goldberg IJ; Bergman M
    Diabetes Res Clin Pract; 2022 Aug; 190():109980. PubMed ID: 35787415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
    Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
    Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherogenic dyslipidemia increases the risk of incident diabetes in statin-treated patients with impaired fasting glucose or obesity.
    Barkas F; Elisaf M; Liberopoulos E; Liamis G; Ntzani EE; Rizos EC
    J Cardiol; 2019 Sep; 74(3):290-295. PubMed ID: 30910387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherosclerotic Cardiovascular Disease or Heart Failure: First Cardiovascular Event in Adults With Prediabetes and Diabetes.
    Sinha A; Ning H; Cameron N; Bancks M; Carnethon MR; Allen NB; Wilkins JT; Lloyd-Jones DM; Khan SS
    J Card Fail; 2023 Mar; 29(3):246-254. PubMed ID: 36343785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyslipidemia in Diabetes: When and How to Treat?
    Goldberg RB
    Endocrinol Metab Clin North Am; 2022 Sep; 51(3):603-624. PubMed ID: 35963631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein(a) levels and risk of cardiovascular disease events in individuals with diabetes mellitus or prediabetes: The Atherosclerosis Risk in Communities study.
    Saeed A; Sun W; Agarwala A; Virani SS; Nambi V; Coresh J; Selvin E; Boerwinkle E; Jones PH; Ballantyne CM; Hoogeveen RC
    Atherosclerosis; 2019 Mar; 282():52-56. PubMed ID: 30685442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
    Rosenblit PD
    Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyslipidemia and reduced total antioxidant status in young adult Saudis with prediabetes.
    Mohieldein AH; Hasan M; Al-Harbi KK; Alodailah SS; Azahrani RM; Al-Mushawwah SA
    Diabetes Metab Syndr; 2015; 9(4):287-91. PubMed ID: 25470641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
    Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
    J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing dyslipidemia in patients with Type 2 diabetes.
    Tomlinson B; Patil NG; Fok M; Lam CWK
    Expert Opin Pharmacother; 2021 Nov; 22(16):2221-2234. PubMed ID: 33823719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988-2014.
    Ali MK; Bullard KM; Saydah S; Imperatore G; Gregg EW
    Lancet Diabetes Endocrinol; 2018 May; 6(5):392-403. PubMed ID: 29500121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New treatment options for lipid-lowering therapy in subjects with type 2 diabetes.
    Scicali R; Di Pino A; Ferrara V; Urbano F; Piro S; Rabuazzo AM; Purrello F
    Acta Diabetol; 2018 Mar; 55(3):209-218. PubMed ID: 29260404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular Quality of Care Assessment: Clinicians' Adherence to Lipid-Lowering Therapy for Patients with Atherosclerotic Cardiovascular Disease.
    Chan J; Rajalingam T; Fossella J; Zhou H; Eisenberg N; Roche-Nagle G
    Ann Vasc Surg; 2020 Nov; 69():197-205. PubMed ID: 32554202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing Dyslipidemia Management for the Prevention of Cardiovascular Disease: a Focus on Risk Assessment and Therapeutic Options.
    Berman AN; Blankstein R
    Curr Cardiol Rep; 2019 Aug; 21(9):110. PubMed ID: 31378838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting Prediabetes and Diabetes: Agreement between Fasting Plasma Glucose and Oral Glucose Tolerance Test in Thai Adults.
    Aekplakorn W; Tantayotai V; Numsangkul S; Sripho W; Tatsato N; Burapasiriwat T; Pipatsart R; Sansom P; Luckanajantachote P; Chawarokorn P; Thanonghan A; Lakhamkaew W; Mungkung A; Boonkean R; Chantapoon C; Kungsri M; Luanseng K; Chaiyajit K
    J Diabetes Res; 2015; 2015():396505. PubMed ID: 26347060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of various indices derived from an oral glucose tolerance test in the prediction of conversion from prediabetes to type 2 diabetes.
    Kim YA; Ku EJ; Khang AR; Hong ES; Kim KM; Moon JH; Choi SH; Park KS; Jang HC; Lim S
    Diabetes Res Clin Pract; 2014 Nov; 106(2):351-9. PubMed ID: 25245975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretransplantation Oral Glucose Tolerance Test Can Prevent Posttransplant Diabetes Mellitus After Renal Transplantation: Preliminary Study.
    Hap K; Madziarska K; Zmonarski S; Kamińska D; Magott-Procelewska M; Banasik M; Jędrzejak K; Madziarski M; Hap W; Klinger M; Mazanowska O
    Transplant Proc; 2018; 50(6):1776-1780. PubMed ID: 30056899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum lipid and hsCRP levels in prediabetes--impaired fasting glucose (IFG) and impaired glucose tolerance (IGT).
    Chakarova N; Tankova T; Atanassova I; Dakovska L
    Diabetes Res Clin Pract; 2009 Oct; 86(1):56-60. PubMed ID: 19674805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Clinical Guide to Combination Lipid-Lowering Therapy.
    Russell C; Sheth S; Jacoby D
    Curr Atheroscler Rep; 2018 Mar; 20(4):19. PubMed ID: 29516190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of lifestyle interventions on glucose regulation and diabetes risk in adults with impaired glucose tolerance or prediabetes: a meta-analysis.
    Jiang Q; Li JT; Sun P; Wang LL; Sun LZ; Pang SG
    Arch Endocrinol Metab; 2022 Apr; 66(2):157-167. PubMed ID: 35289514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.